Skip to main content
Fig. 7 | Molecular Cancer

Fig. 7

From: miR-377-dependent BCL-xL regulation drives chemotherapeutic resistance in B-cell lymphoid malignancies

Fig. 7

BCL-xL expression identifies CLL patients at high risk for short time to treatment who have negative-prognostic markers. Kaplan-Meier curves for correlation of treatment-free survival in CLL patients with various prognostic markers: a CD38 positive or negative, b CD38 negative with high BCL-xL expression, c ZAP70 positive or negative, d ZAP70 negative with high BCL-xL expression, e 17p deletion or 17p normal/unknown group f 17p normal/unknown group with high BCL-xL expression. Log-rank test P values are shown

Back to article page

Molecular Cancer

ISSN: 1476-4598